Photocure ASA: Renewal of market maker agreement
Oslo, Norway, 26 May 2015: Photocure ASA (OSE: PHO), a specialty pharmaceutical company focused on photodynamic technologies in dermatology and cancer, announces that its market maker agreement with DNB Markets will be replaced with a similar market maker agreement with Norne Securities with effect as of 1 August 2015.
For further information, please contact:
CFO Erik Dahl
Tel: +47 450 55 000, Email: firstname.lastname@example.org